ATTENTION
You must read the following disclaimer before continuing. The following disclaimer applies to the attached Preliminary Offering Memorandum accessed from this page or otherwise received as a result of such access and you are therefore advised to read this disclaimer page carefully before reading, accessing or making any other use of the attached Preliminary Offering Memorandum. In accessing the attached Preliminary Offering Memorandum, you agree to be bound by the following terms and conditions.
THIS PRELIMINARY OFFERING MEMORANDUM IS BEING MADE AVAILABLE ON THE ADVANZ PHARMA’S WEBSITE SOLELY TO COMPLY WITH THE REQUIREMENTS OF RULE 20.1 OF THE CITY CODE ON TAKEOVERS AND MERGERS AND ITS AVAILABILITY DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE TO ANY PERSON IN ANY JURISDICTION.
This copy of the Preliminary Offering Memorandum is not being used, is not intended for use and may not be used, to make an offer of securities directly or indirectly in the United States of America, or by use of the U.S. mail or any U.S. means or instrumentality of U.S. interstate or foreign commerce or any facility of a U.S. national securities exchange. This includes, but is not limited to, facsimile transmission, electronic mail, telex, telephone and the Internet.
Accordingly, copies of this Preliminary Offering Memorandum and any related offering materials available on this website are not being, and must not be, mailed or otherwise transmitted or distributed in or into the United States of America.
You will not transmit this Preliminary Offering Memorandum (or any copy of it or part thereof) or disclose, whether orally or in writing, any of its contents to any other person. Any forwarding, distribution or reproduction of this document in whole or in part is unauthorized.
Any attempt to circumvent these restrictions with respect to this Preliminary Offering Memorandum is not permitted and may subject you to liability.
